Press release
The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030, predicts Roots Analysis
Roots Analysis is pleased to announce the publication of its recent study, titled, “Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030.”
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html
The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade. The study features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:
A detailed assessment of the current market landscape of drug developers engaged in the development of bispecific antibody therapeutics.
A comprehensive analysis of novel technology platforms that are either currently available or being developed for the generation of bispecific antibody therapeutics.
Detailed profiles of marketed and clinical stage (phase II and phase III) bispecific antibody therapeutics.
Key takeaways from the bispecific antibody therapeutics pipeline.
An analysis of the initiatives of big biopharma players engaged in this domain.
An analysis of recent partnerships and collaboration agreements inked in bispecific antibody therapeutics domain.
A review on the key steps involved and challenges associated with the manufacturing of bispecific antibodies.
A clinical trial analysis of ongoing and planned studies related to bispecific antibody therapeutics.
A review of the key promotional strategies that have been adopted by the developers of the marketed bispecific antibodies.
A discussion on important, industry-specific trends, key market drivers and challenges, under a SWOT framework.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Target Disease Indication
Autoimmune Disorders
Eye Disorders
Genetic Disorders
Hematological Malignancies
Infectious Diseases
Inflammatory Disorders
Skin Disorders
Mechanism of Action
Cytokines Retargeting / Neutralization
Dual Ligands Blocking
T-cell Retargeting / Activation
Others
Target Antigens
CD3 x CD19
CD30 x CD16A
Factor IXa x Factor X
IL-1α x IL-1β
IL-13 x IL-4
IL-17A x Albumin
IL-17A x IL-17F
Psl x PcrV
TNF-α x HAS
VEGF-A x ANG2
Others
Antibody Format
Asymmetric
Fragments
Symmetric
Others
Key Geographical Region
North America
Europe
Asia-Pacific
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html
Transcripts of interviews held with the following senior level representatives of stakeholder companies:
Martin Steiner (Chief Executive Officer, Synimmune)
Ludger Große-Hovest (Chief Scientific Officer, Synimmune)
Jane Dancer (Chief Business Officer, F-Star)
Siobhan Pomeroy (Senior Director, Business Development, Cytom X)
Yinjue Wang (Associate Director, Process Development, Innovent Biologics)
Key companies covered in the report
Amgen
Ablynx
AbbVie
Affibody
Affimed
Alphamab
AstraZeneca
Avillion
Chugai Pharmaceuticals
Eddingpharm
GSK
Merck
Merus
Roche
Regeneron Pharmaceuticals
Taisho Pharmaceuticals
Zymeworks
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html
Other Recent Offerings
1. Global Preventive Vaccines Market, 2020-2030
2. Endocannabinoid System Targeted Therapeutics Market, 2019-2030
3. Antibody Contract Manufacturing Market, 2020-2030
Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030, predicts Roots Analysis here
News-ID: 2194951 • Views: …
More Releases from Roots Analysis
Prefilled Syringes Market Size to Hit USD 4.97 billion by 2035| Exclusive Report …
Prefilled syringes: setting new standards for safe and efficient drug administration. With the increasing population, the incidence rates of various chronic diseases, such as diabetes, autoimmune disorders, cardiovascular disorders and oncological disorders, are witnessing an upward trend.
The global prefilled syringes market, valued at USD 3.02 billion in 2024, is project to reach USD 3.19 billion in 2025 and USD 4.97 billion by 2035, representing a CAGR of 4.5% during the…
CRISPR Gene Editing Therapies Market Size to Grow at CAGR of 129% | Exclusive Re …
The new market research report titled 'CRISPR Gene Editing Therapies Market', published by Roots Analysis offers a comprehensive study of the CRISPR Gene Editing Therapies Market, while estimating the overall market size and the size and share of the key regional segments of the global market over historical period, as well as the projected timeline till 2035.
According to Roots Analysis, the CRISPR gene editing therapies market is estimated to…
Digital Therapeutics Market Size to Hit USD 19.76 billion by 2035| Exclusive Rep …
Digital therapeutics - the increasing regulatory support has facilitated the establishment of a standard developmental pathway for these solutions
Digital therapeutics are clinically validated applications / software / online programs that have demonstrated the capability to facilitate positive outcomes when used in the prevention / treatment / management of diseases / clinical conditions. These therapeutics are designed to engage patients in personalized treatment or disease prevention programs, through mediating behavioral or…
Precision Farming Market Size to Hit USD 27.3 billion by 2035| Exclusive Report …
Driven by the ongoing efforts to overcome the inefficiencies related to conventional farming practices, the market is likely to present lucrative opportunities for precision farming companies in coming years
The precision farming market is estimated to grow from USD 10.4 billion in 2024 to reach USD 11.2 billion in 2025 and USD 27.3 billion by 2035, representing a higher CAGR of 9.3% during the forecast period.
To request quote of this report,…
More Releases for Disorders
Bleeding Disorders Market Is Driven By Bleeding Disorders In Various Industries, …
The Bleeding Disorders Market is a critical component of the healthcare industry, focused on the diagnosis, treatment, and management of bleeding disorders that affect individuals' blood clotting mechanisms. These disorders, which include hemophilia, von Willebrand disease, and various clotting factor deficiencies, can lead to prolonged and spontaneous bleeding, posing significant health risks. This market encompasses a range of therapies, medications, and diagnostic tools designed to address the unique needs of…
Gene Therapy For Rare Disease Market By Therapeutic Application ( Oncology, Neur …
The Gene Therapy For Rare Disease Market report outlines the evolution of Gene Therapy For Rare Disease industry by type, applications and identifies and assesses the best performing vendors in the market till 2028. Gene Therapy For Rare Disease Market reports present the revenue opportunities in the Gene Therapy For Rare Disease industry through 2023-2028, highlighting the market size and growth by technology, geography, vertical and End users.
Download Sample PDF…
Neuroprosthetics Market 2019 Industry Segmentation by physiological disorders ar …
Neuroprosthetics Market 2019 Scenario
Neuroprosthetics Market was estimated to be USD 5.28 billion in 2016 and expected to reach USD 10.48 billion by 2023. The key factors responsible for driving this are increasing in geriatric population, auditory processing disorders in kids, and increase in spinal cord treatment due to advancement in neuroprosthetics devices.
The factors responsible for the positive growth of this market are increasing prevalence of neural diseases, over active bladder…
Global Vocal Biomarker Market to Experience Significant Growth during the Foreca …
Vocal patterns have been used by clinical psychologists and psychoanalysts for analyzing personality traits of patients, and helping creation of headway in clinical and medical investigations. Recent breakthroughs in the healthcare sector have led to the development of a unique diagnostic tool known as Vocal Biomarker Market by combining the concept of biological markers with the aforementioned methodology to analyze personality traits.
Claim Sample Report For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=719
These vocal biomarkers are…
Behavioral Therapy Market Report 2018: Segmentation by Type (Anxiety Disorders, …
Global Behavioral Therapy market research report provides company profile for American Addiction Centers, ChanceLight, Haven Behavioral Healthcare, Behavioral Health Group, Center for Autism & Related Disorders, People’s Care, Magellan Health, Universal Health Services, Acadia Healthcare, Springstone and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY…
Biopharmaceuticals Market Outlook 2025|( Biopharmaceuticals Application:- Infect …
Global Biopharmaceuticals Market Research Report Brief Focus On Study About Biopharmaceuticals Market Industry volume, Market Revenue, Market Segments , Market Trends ,Growth aspects A wide range of applications, Utilization ratio, Supply and demand analysis are also consist in the report such as:
Biopharmaceuticals Product Type:- Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Synthetic Immunomodulators, Vaccines,
Biopharmaceuticals Application :- Inflammatory , Infectious Diseases, Autoimmune Disorders, Metabolic…
